Tirzepatide clinical trials: 76 trials
Page 1 of 2
Read 76 Tirzepatide clinical trials with posted results or linked papers with results in PepBank.
- A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes
NCT04255433 · Phase 3 · Completed
Posted results
- A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight
NCT04184622 · Phase 3 · Completed
Posted results
- A Study of Tirzepatide (LY3298176) Once a Week Versus Insulin Glargine Once a Day in Participants With Type 2 Diabetes and Increased Cardiovascular Risk
NCT03730662 · Phase 3 · Completed
Posted results
- A Study of Tirzepatide (LY3298176) Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Participants With Type 2 Diabetes
NCT03987919 · Phase 3 · Completed
Posted results
- A Study of Tirzepatide (LY3298176) Versus Insulin Degludec in Participants With Type 2 Diabetes
NCT03882970 · Phase 3 · Completed
Posted results
- A Study of Tirzepatide (LY3298176) Versus Insulin Lispro (U100) in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin
NCT04537923 · Phase 3 · Completed
Posted results
- A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Who Have Obesity or Are Overweight
NCT04657003 · Phase 3 · Completed
Posted results
- A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes on Metformin With or Without Sulfonylurea (SURPASS-AP-Combo)
NCT04093752 · Phase 3 · Completed
Posted results
- A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight for the Maintenance of Weight Loss
NCT04660643 · Phase 3 · Completed
Posted results
- A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight With Weight Related Comorbidities
NCT05822830 · Phase 3 · Completed
Posted results
- A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) and Obesity: The SUMMIT Trial
NCT04847557 · Phase 3 · Completed
Posted results
- A Study of Tirzepatide (LY3298176) Compared to Dulaglutide in Participants With Type 2 Diabetes
NCT03861052 · Phase 3 · Completed
Posted results
- A Study of Tirzepatide (LY3298176) In Participants After A Lifestyle Weight Loss Program
NCT04657016 · Phase 3 · Completed
Posted results
- A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone
NCT03954834 · Phase 3 · Completed
Posted results
- A Study of Tirzepatide (LY3298176) Versus Placebo in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine With or Without Metformin
NCT04039503 · Phase 3 · Completed
Posted results
- Obstructive Sleep Apnea Master Protocol GPIF: A Study of Tirzepatide (LY3298176) in Participants With Obstructive Sleep Apnea
NCT05412004 · Phase 3 · Completed
Posted results
- A Long-term Safety Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes
NCT03861039 · Phase 3 · Completed
Posted results
- A Study of Tirzepatide (LY3298176) in Adult Participants With Type 2 Diabetes Switching From Dulaglutide (SURPASS-SWITCH)
NCT05564039 · Phase 4 · Completed
Posted results
- A Study of Tirzepatide (LY3298176) in Participants With Obesity Disease
NCT04844918 · Phase 3 · Completed
Posted results
- A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes
NCT05691712 · Phase 3 · Completed
Posted results
- A Study of Tirzepatide (LY3298176) in Chinese Participants Without Type 2 Diabetes Who Have Obesity or Overweight (SURMOUNT-CN)
NCT05024032 · Phase 3 · Completed
Posted results
- A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes (SURPASS-CN-MONO)
NCT05963022 · Phase 3 · Completed
Posted results
- A Study of Tirzepatide (LY3298176) in Adults With Type 2 Diabetes Switching From a GLP-1 RA (SURPASS-SWITCH-2)
NCT05706506 · Phase 4 · Completed
Posted results
- A Study to Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin or Basal Insulin or Both
NCT05260021 · Phase 3 · Completed
Posted results
- Holding vs. Continuing Incretin-based Therapies Before Upper Endoscopy
NCT06533527 · Phase 4 · Completed
Posted results
- A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 Diabetes
NCT05433584 · Phase 4 · Active, not recruiting
Linked paper with results
- Tirzepatide in Thrombectomy-Treated Acute Ischemic Stroke: A Randomized Trial
NCT07734792 · Phase 2/3 · Not yet recruiting
Linked paper with results
- Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Psoriatic Arthritis and Obesity or Overweight
NCT06588296 · Phase 3 · Completed
Linked paper with results
- The Effects of Tirzepatide in People With Overweight/Obesity and Coronary Artery Disease
NCT06606821 · Phase 4 · Recruiting
Linked paper with results
- A Clinical Trial Using Tirzepatide to Help Adults With Type 1 Diabetes Automatically Control Their Blood Sugar
NCT07284511 · Phase 2/3 · Recruiting
Linked paper with results
- Evaluation of the Efficacy and Safety of Tirzepatide, a Dual GLP-1/GIP Agonist, on Functional Capacity in Reduced Ejection Fraction Heart Failure Patients With Obesity
NCT07738276 · Phase 3 · Not yet recruiting
Linked paper with results
- GLP-1R Actions on Muscle and the Skeleton
NCT07154719 · Phase 4 · Recruiting
Linked paper with results
- Tirzepatide for Ileal Pouch-anal Anastomosis (IPAA) and Chronic High Bowel Frequency (I8F-NS-X008)
NCT07756359 · Phase 4 · Not yet recruiting
Linked paper with results
- A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Mellitus
NCT03131687 · Phase 2 · Completed
Posted results
- A Study of Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH)
NCT04166773 · Phase 2 · Completed
Posted results
- A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes
NCT03311724 · Phase 2 · Completed
Posted results
- A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes
NCT05536804 · Phase 2 · Completed
Linked paper with results
- Tirzepatide in MetALD
NCT07046819 · Phase 2 · Recruiting
Linked paper with results
- Efficacy and Safety of Apitegromab for the Treatment of Adults Who Are Overweight or Obese
NCT06445075 · Phase 2 · Completed
Linked paper with results
- Acute Metabolic Effects of Tirzepatide in Type 1 Diabetes
NCT06820281 · Phase 2 · Recruiting
Linked paper with results
- Tirzepatide for Obesity and Meth Use Disorder
NCT06745128 · Phase 2 · Completed
Linked paper with results
- Tirzepatide Following Adrenalectomy in Mild Autonomous Cortisol Secretion
NCT07573163 · Phase 2 · Recruiting
Linked paper with results
- GLP-1 Agonists for Lung Function Improvement and Muscle Restoration in COPD
NCT07747805 · Phase 2 · Not yet recruiting
Linked paper with results
- Effects of Tirzepatide on Muscle and Vascular Health in Obese Older Adults
NCT06811324 · Phase 2 · Recruiting
Linked paper with results
- Effects of Tirzepatide on Weight Loss and Chronic Inflammation in People With HIV
NCT06935838 · Phase 2 · Completed
Linked paper with results
- A Study of Tirzepatide (LY3298176) in Healthy Participants and Participants With Type 2 Diabetes (T2DM)
NCT02759107 · Phase 1 · Completed
Posted results
- A Study of Tirzepatide in Participants With Type 2 Diabetes Mellitus (T2DM)
NCT03951753 · Phase 1 · Completed
Posted results
- A Study of Tirzepatide in Overweight and Very Overweight Participants
NCT04311411 · Phase 1 · Completed
Posted results
- A Research Study Looking at Similarity Between Tirzepatide Versions for Different Injection Devices
NCT05810597 · Phase 1 · Completed
Posted results
- A Study to Measure Energy Expenditure and Food Intake in Participants With Obesity Using Tirzepatide
NCT04081337 · Phase 1 · Completed
Posted results